POPULARITY
185 episodes with aspn
89 episodes with aspn
50 episodes with aspn
22 episodes with aspn
29 episodes with aspn
22 episodes with aspn
26 episodes with aspn
13 episodes with aspn
16 episodes with aspn
10 episodes with aspn
12 episodes with aspn
9 episodes with aspn
5 episodes with aspn
10 episodes with aspn
5 episodes with aspn
3 episodes with aspn
2 episodes with aspn
2 episodes with aspn
Summary In this Pain Exam Podcast episode, Dr. David Rosenblum discusses a journal club article on low volume neurolytic retrocrural celiac plexus blocks for visceral cancer pain. The study reviewed 507 patients with severe malignancy-related abdominal pain, with data retained for 455 patients at the 5-month mark. Dr. Rosenblum explains that the procedure involves injecting 3-5ml of 6% aqueous phenol at the T12-L1 level under fluoroscopic guidance, with an average procedure time of 16.3 minutes. The study found significant pain relief lasting up to six months, reduced opioid consumption, and improved quality of life for patients with primary abdominal cancer or metastatic disease. Dr. Rosenblum shares his personal experience with celiac plexus blocks, including the trans-aortic approach he trained on, and mentions his interest in ultrasound-guided approaches. He also announces upcoming teaching engagements at ASPN, Pain Week, and other conferences, as well as CME ultrasound courses available through nrappain.org. Additionally, he mentions a new community page on the website where users can share board preparation information, though he emphasizes that remembered board questions should not be posted as he is a board question writer himself. Pain Management Board Prep Ultrasound Training REGISTER TODAY! Create an Account and get Free Access to the PainExam- NRAP Academy Community Highlights Introduction and Upcoming Events Dr. David Rosenblum introduces the Pain Exam Podcast and shares information about upcoming events. He mentions teaching ultrasound at ASPN in July, attending Pain Week in September, and participating in the Latin American Pain Society conference. Dr. Rosenblum also promotes his CME ultrasound courses available at nrappain.org and mentions he's considering organizing another regenerative medicine course in fall or winter. He offers private training for those wanting more intensive ultrasound instruction. Board Prep Community Announcement Dr. Rosenblum announces a new community page on the nrappain.org website for board preparation. He explains that registered users can access free information and keywords relevant to board exams. He emphasizes that users should not post remembered questions as this would be inappropriate, noting that he himself is a board question writer for various pain boards. Dr. Rosenblum mentions that a post about phenol in this community inspired today's podcast topic. Journal Article Overview on Celiac Plexus Block Dr. Rosenblum introduces a journal article on low volume neurolytic retrocrural celiac plexus block for visceral cancer pain, a retrospective review of 507 patients with severe malignancy-related abdominal pain. He explains that the study assessed pain relief provided by this procedure, its duration, reduction in daily opioid consumption, and quality of life improvements. The patients received neurolytic blocks without previous diagnostic blocks due to multiple comorbidities, which Dr. Rosenblum acknowledges is sometimes necessary with very sick patients despite the typical preference for diagnostic blocks before neurolysis. Dr. Rosenblum's Personal Experience with Celiac Plexus Blocks Dr. Rosenblum shares his personal training experience with trans-aortic celiac plexus blocks, where a needle is inserted through the aorta after confirming no plaques or aneurysms are present. He describes it as a safe and effective procedure despite sounding intimidating. He mentions he's only performed a handful of these procedures and doesn't do many now as an outpatient pain doctor. Study Methods and Results Dr. Rosenblum details the study methods, noting that of 507 patients studied, data for 455 was retained at the end of the review. Patients were evaluated before and after the neurolytic retrocrural celiac plexus block under fluoroscopic guidance. Assessment included procedure duration, pain scores (0-10 scale), daily opioid consumption, and quality of life improvement. Follow-up was completed six months after the procedure, showing improved pain scores, reduced opioid consumption, and better quality of life throughout the study period. Some pain returned during months 4-6 due to disease progression and the anticipated duration of the neurolytic agent. The study noted a 6.7% initial vascular contrast uptake during the procedure while using digital subtraction angiography with fluoroscopy. Study Limitations and Conclusions Dr. Rosenblum discusses the study's limitations, including the need for a larger sample size and a prospective trial with a control group, though he acknowledges this is unrealistic given the patient population. He mentions that a proven quality of life questionnaire would be beneficial, and that comparing alcohol, phenol, and RF thermocoagulation would be interesting to evaluate duration effects and side effects. The study concluded that low volume neurolytic retrocrural celiac plexus block with phenol is safe, providing up to six months of pain relief for abdominal pain due to primary malignancy or metastatic spread. Detailed Procedure Technique Dr. Rosenblum explains the detailed procedure technique used in the study. The retrocrural celiac plexus was targeted at L1 level with aim towards T12. Anterior and posterior radiographic imaging aligning the spinous process of T12-L1 junction was used with 15-20 degree oblique rotation. Local anesthetic (1% lidocaine with sodium bicarbonate) was infiltrated along the injection path. A 22 or 25 gauge 3.5-7 inch curved spinal needle was used depending on patient body habitus. Dr. Rosenblum notes he typically uses a 6-inch Chiba needle or 25 gauge spinal needle for such procedures. Procedure Execution and Monitoring Dr. Rosenblum continues describing the procedure, noting that the needle was advanced to the anterior border of T12-L1 under multiple imaging views. Contrast dye studies verified spread and location, with digital subtraction angiography used to check for intravascular uptake. A test dose of 1ml of 0.5% bupivacaine with epinephrine per site was administered, which Dr. Rosenblum finds interesting as he typically doesn't mix bupivacaine with epinephrine. After confirming no vascular uptake, 3-5ml of 6% aqueous phenol was injected in 1ml aliquots while communicating with the patient. The average procedure time was 16.3 minutes with minimal or no sedation. Patients remained prone for 30 minutes afterward to avoid neuroforaminal spread, as phenol is heavier and more viscous than alcohol. Post-Procedure Care and Study Evaluation Dr. Rosenblum explains that patients were monitored in recovery for one hour for adverse events and their ability to eat and void easily. They were discharged once hospital post-anesthetic criteria were met and received a follow-up call 24 hours later. Dr. Rosenblum praises the study and notes that the procedure looks similar to a lumbar sympathetic plexus block, which is also a sympathetic block. Ultrasound Considerations and Alternative Approaches Dr. Rosenblum shares his interest in ultrasound-guided celiac plexus blocks but acknowledges concerns about bowel perforation. He mentions a conversation with an interventional radiology colleague who suggested a transhepatic approach. Dr. Rosenblum recalls scanning a very thin patient where the aorta was easily visible and close to the anterior abdominal wall, making the celiac plexus potentially accessible if bowel perforation, liver bleeding, or gallbladder perforation could be avoided. He shares an experience with a patient suffering from severe pancreatitis pain who received temporary relief from a paravertebral thoracic nerve block at T8-T10, noting that paravertebral blocks provide some sympathetic spread. Conclusion and Community Resource Reminder Dr. Rosenblum concludes by recommending the article, noting its well-written analysis and graphs showing morphine consumption dropping over months following the procedure. He suggests neurolytic procedures are underutilized because they sound intimidating. He again encourages listeners to check out the community he created with separate chat rooms for regenerative medicine, regional anesthesia, and pain boards, where users can share keywords but not specific board questions. Dr. Rosenblum reminds listeners about upcoming courses and his website resources, mentions an upcoming PRP lecture, and asks for five-star reviews if listeners enjoy the podcast. The episode ends with a standard medical disclaimer. Reference https://www.painphysicianjournal.com/current/pdf?article=NTQwOA%3D%3D&journal=113
Summary In this Pain Exam Podcast episode, Dr. David Rosenblum discusses a journal club article on low volume neurolytic retrocrural celiac plexus blocks for visceral cancer pain. The study reviewed 507 patients with severe malignancy-related abdominal pain, with data retained for 455 patients at the 5-month mark. Dr. Rosenblum explains that the procedure involves injecting 3-5ml of 6% aqueous phenol at the T12-L1 level under fluoroscopic guidance, with an average procedure time of 16.3 minutes. The study found significant pain relief lasting up to six months, reduced opioid consumption, and improved quality of life for patients with primary abdominal cancer or metastatic disease. Dr. Rosenblum shares his personal experience with celiac plexus blocks, including the trans-aortic approach he trained on, and mentions his interest in ultrasound-guided approaches. He also announces upcoming teaching engagements at ASPN, Pain Week, and other conferences, as well as CME ultrasound courses available through nrappain.org. Additionally, he mentions a new community page on the website where users can share board preparation information, though he emphasizes that remembered board questions should not be posted as he is a board question writer himself. Pain Management Board Prep Ultrasound Training REGISTER TODAY! Create an Account and get Free Access to the PainExam- NRAP Academy Community Highlights Introduction and Upcoming Events Dr. David Rosenblum introduces the Pain Exam Podcast and shares information about upcoming events. He mentions teaching ultrasound at ASPN in July, attending Pain Week in September, and participating in the Latin American Pain Society conference. Dr. Rosenblum also promotes his CME ultrasound courses available at nrappain.org and mentions he's considering organizing another regenerative medicine course in fall or winter. He offers private training for those wanting more intensive ultrasound instruction. Board Prep Community Announcement Dr. Rosenblum announces a new community page on the nrappain.org website for board preparation. He explains that registered users can access free information and keywords relevant to board exams. He emphasizes that users should not post remembered questions as this would be inappropriate, noting that he himself is a board question writer for various pain boards. Dr. Rosenblum mentions that a post about phenol in this community inspired today's podcast topic. Journal Article Overview on Celiac Plexus Block Dr. Rosenblum introduces a journal article on low volume neurolytic retrocrural celiac plexus block for visceral cancer pain, a retrospective review of 507 patients with severe malignancy-related abdominal pain. He explains that the study assessed pain relief provided by this procedure, its duration, reduction in daily opioid consumption, and quality of life improvements. The patients received neurolytic blocks without previous diagnostic blocks due to multiple comorbidities, which Dr. Rosenblum acknowledges is sometimes necessary with very sick patients despite the typical preference for diagnostic blocks before neurolysis. Dr. Rosenblum's Personal Experience with Celiac Plexus Blocks Dr. Rosenblum shares his personal training experience with trans-aortic celiac plexus blocks, where a needle is inserted through the aorta after confirming no plaques or aneurysms are present. He describes it as a safe and effective procedure despite sounding intimidating. He mentions he's only performed a handful of these procedures and doesn't do many now as an outpatient pain doctor. Study Methods and Results Dr. Rosenblum details the study methods, noting that of 507 patients studied, data for 455 was retained at the end of the review. Patients were evaluated before and after the neurolytic retrocrural celiac plexus block under fluoroscopic guidance. Assessment included procedure duration, pain scores (0-10 scale), daily opioid consumption, and quality of life improvement. Follow-up was completed six months after the procedure, showing improved pain scores, reduced opioid consumption, and better quality of life throughout the study period. Some pain returned during months 4-6 due to disease progression and the anticipated duration of the neurolytic agent. The study noted a 6.7% initial vascular contrast uptake during the procedure while using digital subtraction angiography with fluoroscopy. Study Limitations and Conclusions Dr. Rosenblum discusses the study's limitations, including the need for a larger sample size and a prospective trial with a control group, though he acknowledges this is unrealistic given the patient population. He mentions that a proven quality of life questionnaire would be beneficial, and that comparing alcohol, phenol, and RF thermocoagulation would be interesting to evaluate duration effects and side effects. The study concluded that low volume neurolytic retrocrural celiac plexus block with phenol is safe, providing up to six months of pain relief for abdominal pain due to primary malignancy or metastatic spread. Detailed Procedure Technique Dr. Rosenblum explains the detailed procedure technique used in the study. The retrocrural celiac plexus was targeted at L1 level with aim towards T12. Anterior and posterior radiographic imaging aligning the spinous process of T12-L1 junction was used with 15-20 degree oblique rotation. Local anesthetic (1% lidocaine with sodium bicarbonate) was infiltrated along the injection path. A 22 or 25 gauge 3.5-7 inch curved spinal needle was used depending on patient body habitus. Dr. Rosenblum notes he typically uses a 6-inch Chiba needle or 25 gauge spinal needle for such procedures. Procedure Execution and Monitoring Dr. Rosenblum continues describing the procedure, noting that the needle was advanced to the anterior border of T12-L1 under multiple imaging views. Contrast dye studies verified spread and location, with digital subtraction angiography used to check for intravascular uptake. A test dose of 1ml of 0.5% bupivacaine with epinephrine per site was administered, which Dr. Rosenblum finds interesting as he typically doesn't mix bupivacaine with epinephrine. After confirming no vascular uptake, 3-5ml of 6% aqueous phenol was injected in 1ml aliquots while communicating with the patient. The average procedure time was 16.3 minutes with minimal or no sedation. Patients remained prone for 30 minutes afterward to avoid neuroforaminal spread, as phenol is heavier and more viscous than alcohol. Post-Procedure Care and Study Evaluation Dr. Rosenblum explains that patients were monitored in recovery for one hour for adverse events and their ability to eat and void easily. They were discharged once hospital post-anesthetic criteria were met and received a follow-up call 24 hours later. Dr. Rosenblum praises the study and notes that the procedure looks similar to a lumbar sympathetic plexus block, which is also a sympathetic block. Ultrasound Considerations and Alternative Approaches Dr. Rosenblum shares his interest in ultrasound-guided celiac plexus blocks but acknowledges concerns about bowel perforation. He mentions a conversation with an interventional radiology colleague who suggested a transhepatic approach. Dr. Rosenblum recalls scanning a very thin patient where the aorta was easily visible and close to the anterior abdominal wall, making the celiac plexus potentially accessible if bowel perforation, liver bleeding, or gallbladder perforation could be avoided. He shares an experience with a patient suffering from severe pancreatitis pain who received temporary relief from a paravertebral thoracic nerve block at T8-T10, noting that paravertebral blocks provide some sympathetic spread. Conclusion and Community Resource Reminder Dr. Rosenblum concludes by recommending the article, noting its well-written analysis and graphs showing morphine consumption dropping over months following the procedure. He suggests neurolytic procedures are underutilized because they sound intimidating. He again encourages listeners to check out the community he created with separate chat rooms for regenerative medicine, regional anesthesia, and pain boards, where users can share keywords but not specific board questions. Dr. Rosenblum reminds listeners about upcoming courses and his website resources, mentions an upcoming PRP lecture, and asks for five-star reviews if listeners enjoy the podcast. The episode ends with a standard medical disclaimer. Reference https://www.painphysicianjournal.com/current/pdf?article=NTQwOA%3D%3D&journal=113
Summary In this Pain Exam Podcast episode, Dr. David Rosenblum discusses a journal club article on low volume neurolytic retrocrural celiac plexus blocks for visceral cancer pain. The study reviewed 507 patients with severe malignancy-related abdominal pain, with data retained for 455 patients at the 5-month mark. Dr. Rosenblum explains that the procedure involves injecting 3-5ml of 6% aqueous phenol at the T12-L1 level under fluoroscopic guidance, with an average procedure time of 16.3 minutes. The study found significant pain relief lasting up to six months, reduced opioid consumption, and improved quality of life for patients with primary abdominal cancer or metastatic disease. Dr. Rosenblum shares his personal experience with celiac plexus blocks, including the trans-aortic approach he trained on, and mentions his interest in ultrasound-guided approaches. He also announces upcoming teaching engagements at ASPN, Pain Week, and other conferences, as well as CME ultrasound courses available through nrappain.org. Additionally, he mentions a new community page on the website where users can share board preparation information, though he emphasizes that remembered board questions should not be posted as he is a board question writer himself. Pain Management Board Prep Ultrasound Training REGISTER TODAY! Create an Account and get Free Access to the PainExam- NRAP Academy Community Highlights Introduction and Upcoming Events Dr. David Rosenblum introduces the Pain Exam Podcast and shares information about upcoming events. He mentions teaching ultrasound at ASPN in July, attending Pain Week in September, and participating in the Latin American Pain Society conference. Dr. Rosenblum also promotes his CME ultrasound courses available at nrappain.org and mentions he's considering organizing another regenerative medicine course in fall or winter. He offers private training for those wanting more intensive ultrasound instruction. Board Prep Community Announcement Dr. Rosenblum announces a new community page on the nrappain.org website for board preparation. He explains that registered users can access free information and keywords relevant to board exams. He emphasizes that users should not post remembered questions as this would be inappropriate, noting that he himself is a board question writer for various pain boards. Dr. Rosenblum mentions that a post about phenol in this community inspired today's podcast topic. Journal Article Overview on Celiac Plexus Block Dr. Rosenblum introduces a journal article on low volume neurolytic retrocrural celiac plexus block for visceral cancer pain, a retrospective review of 507 patients with severe malignancy-related abdominal pain. He explains that the study assessed pain relief provided by this procedure, its duration, reduction in daily opioid consumption, and quality of life improvements. The patients received neurolytic blocks without previous diagnostic blocks due to multiple comorbidities, which Dr. Rosenblum acknowledges is sometimes necessary with very sick patients despite the typical preference for diagnostic blocks before neurolysis. Dr. Rosenblum's Personal Experience with Celiac Plexus Blocks Dr. Rosenblum shares his personal training experience with trans-aortic celiac plexus blocks, where a needle is inserted through the aorta after confirming no plaques or aneurysms are present. He describes it as a safe and effective procedure despite sounding intimidating. He mentions he's only performed a handful of these procedures and doesn't do many now as an outpatient pain doctor. Study Methods and Results Dr. Rosenblum details the study methods, noting that of 507 patients studied, data for 455 was retained at the end of the review. Patients were evaluated before and after the neurolytic retrocrural celiac plexus block under fluoroscopic guidance. Assessment included procedure duration, pain scores (0-10 scale), daily opioid consumption, and quality of life improvement. Follow-up was completed six months after the procedure, showing improved pain scores, reduced opioid consumption, and better quality of life throughout the study period. Some pain returned during months 4-6 due to disease progression and the anticipated duration of the neurolytic agent. The study noted a 6.7% initial vascular contrast uptake during the procedure while using digital subtraction angiography with fluoroscopy. Study Limitations and Conclusions Dr. Rosenblum discusses the study's limitations, including the need for a larger sample size and a prospective trial with a control group, though he acknowledges this is unrealistic given the patient population. He mentions that a proven quality of life questionnaire would be beneficial, and that comparing alcohol, phenol, and RF thermocoagulation would be interesting to evaluate duration effects and side effects. The study concluded that low volume neurolytic retrocrural celiac plexus block with phenol is safe, providing up to six months of pain relief for abdominal pain due to primary malignancy or metastatic spread. Detailed Procedure Technique Dr. Rosenblum explains the detailed procedure technique used in the study. The retrocrural celiac plexus was targeted at L1 level with aim towards T12. Anterior and posterior radiographic imaging aligning the spinous process of T12-L1 junction was used with 15-20 degree oblique rotation. Local anesthetic (1% lidocaine with sodium bicarbonate) was infiltrated along the injection path. A 22 or 25 gauge 3.5-7 inch curved spinal needle was used depending on patient body habitus. Dr. Rosenblum notes he typically uses a 6-inch Chiba needle or 25 gauge spinal needle for such procedures. Procedure Execution and Monitoring Dr. Rosenblum continues describing the procedure, noting that the needle was advanced to the anterior border of T12-L1 under multiple imaging views. Contrast dye studies verified spread and location, with digital subtraction angiography used to check for intravascular uptake. A test dose of 1ml of 0.5% bupivacaine with epinephrine per site was administered, which Dr. Rosenblum finds interesting as he typically doesn't mix bupivacaine with epinephrine. After confirming no vascular uptake, 3-5ml of 6% aqueous phenol was injected in 1ml aliquots while communicating with the patient. The average procedure time was 16.3 minutes with minimal or no sedation. Patients remained prone for 30 minutes afterward to avoid neuroforaminal spread, as phenol is heavier and more viscous than alcohol. Post-Procedure Care and Study Evaluation Dr. Rosenblum explains that patients were monitored in recovery for one hour for adverse events and their ability to eat and void easily. They were discharged once hospital post-anesthetic criteria were met and received a follow-up call 24 hours later. Dr. Rosenblum praises the study and notes that the procedure looks similar to a lumbar sympathetic plexus block, which is also a sympathetic block. Ultrasound Considerations and Alternative Approaches Dr. Rosenblum shares his interest in ultrasound-guided celiac plexus blocks but acknowledges concerns about bowel perforation. He mentions a conversation with an interventional radiology colleague who suggested a transhepatic approach. Dr. Rosenblum recalls scanning a very thin patient where the aorta was easily visible and close to the anterior abdominal wall, making the celiac plexus potentially accessible if bowel perforation, liver bleeding, or gallbladder perforation could be avoided. He shares an experience with a patient suffering from severe pancreatitis pain who received temporary relief from a paravertebral thoracic nerve block at T8-T10, noting that paravertebral blocks provide some sympathetic spread. Conclusion and Community Resource Reminder Dr. Rosenblum concludes by recommending the article, noting its well-written analysis and graphs showing morphine consumption dropping over months following the procedure. He suggests neurolytic procedures are underutilized because they sound intimidating. He again encourages listeners to check out the community he created with separate chat rooms for regenerative medicine, regional anesthesia, and pain boards, where users can share keywords but not specific board questions. Dr. Rosenblum reminds listeners about upcoming courses and his website resources, mentions an upcoming PRP lecture, and asks for five-star reviews if listeners enjoy the podcast. The episode ends with a standard medical disclaimer. Reference https://www.painphysicianjournal.com/current/pdf?article=NTQwOA%3D%3D&journal=113
PRP in the Epidural Space for Radiculopathy Brooklyn Based Pain Physician, David Rosenblum, MD known for his work publishing and teaching Regenerative Pain Medicine and Ultrasound Guided Pain Procedures hosts this podcast covering the latest and most advanced concepts in Pain Medicine. Summary Dr. David Rosenblum delivered a comprehensive lecture covering several key topics in pain management. He discussed his upcoming speaking engagements at PainWeek, ASPN and great upcoming meetings like the Latin American Pain Society, and other conferences. Dr. Rosenblum shared his extensive experience with PRP (Platelet-Rich Plasma) epidural injections, reviewing multiple research studies that support their efficacy. He highlighted three significant studies: a randomized control trial comparing PRP epidural injections to traditional treatments, a CT-guided epidural PRP study, and a 2025 meta-analysis comparing PRP to steroids. Dr. Rosenblum emphasized that PRP treatments are showing comparable or better results than traditional steroid injections, with potentially fewer required treatments and longer-lasting relief. He noted that while PRP is currently not covered by insurance, it represents a growing trend in 'natural' treatment approaches that patients increasingly prefer. Chapters Introduction and Upcoming Events Dr. Rosenblum announced his upcoming lectures at Pain Week focusing on ultrasound and regenerative medicine, followed by presentations at the Latin American Pain Society in Chile and the New York, New Jersey Pain Conference. He mentioned the SoMeDocs online pain conference accessible through nrappain.org, and upcoming ultrasound training sessions in New York City. PRP Epidural Research Review Dr. Rosenblum discussed a randomized control trial involving 30 patients receiving transforaminal epidural injections. The study showed that PRP patients demonstrated significant improvements in leg pain scores at 6, 12, and 24 weeks. He noted that while the study didn't use contrast, he personally prefers using contrast diluted with saline for better visualization. CT-Guided Epidural Study Analysis Dr. Rosenblum reviewed a study comparing CT-guided epidural PRP versus steroid injections, questioning the necessity of CT guidance. The study included 60 patients and showed similar results between PRP and steroid groups at six weeks, though he criticized the short follow-up period, noting that PRP typically takes months to show full effects. Meta-Analysis Discussion Dr. Rosenblum presented a 2025 meta-analysis comparing PRP to steroids in epidural injections. The analysis included 310 patients across five RCTs, demonstrating comparable efficacy between PRP and steroid injections without increased adverse events. He emphasized that his clinical experience shows patients typically require fewer PRP injections compared to steroid treatments. Register for Next Weeks SoMeDocs Pain Conference References Wongjarupong, Asarn, et al. "“Platelet-Rich Plasma” epidural injection an emerging strategy in lumbar disc herniation: a Randomized Controlled Trial." BMC Musculoskeletal Disorders 24.1 (2023): 335. Bise, Sylvain, et al. "Comparison of interlaminar CT-guided epidural platelet-rich plasma versus steroid injection in patients with lumbar radicular pain." European radiology 30 (2020): 3152-3160. Muthu S, Viswanathan VK, Gangadaran P. Is platelet-rich plasma better than steroids as epidural drug of choice in lumbar disc disease with radiculopathy? Meta-analysis of randomized controlled trials. Exp Biol Med (Maywood). 2025 Feb 4;250:10390. doi: 10.3389/ebm.2025.10390. PMID: 39968415; PMCID: PMC11832311.
PRP in the Epidural Space for Radiculopathy Brooklyn Based Pain Physician, David Rosenblum, MD known for his work publishing and teaching Regenerative Pain Medicine and Ultrasound Guided Pain Procedures hosts this podcast covering the latest and most advanced concepts in Pain Medicine. Summary Dr. David Rosenblum delivered a comprehensive lecture covering several key topics in pain management. He discussed his upcoming speaking engagements at PainWeek, ASPN and great upcoming meetings like the Latin American Pain Society, and other conferences. Dr. Rosenblum shared his extensive experience with PRP (Platelet-Rich Plasma) epidural injections, reviewing multiple research studies that support their efficacy. He highlighted three significant studies: a randomized control trial comparing PRP epidural injections to traditional treatments, a CT-guided epidural PRP study, and a 2025 meta-analysis comparing PRP to steroids. Dr. Rosenblum emphasized that PRP treatments are showing comparable or better results than traditional steroid injections, with potentially fewer required treatments and longer-lasting relief. He noted that while PRP is currently not covered by insurance, it represents a growing trend in 'natural' treatment approaches that patients increasingly prefer. Chapters Introduction and Upcoming Events Dr. Rosenblum announced his upcoming lectures at Pain Week focusing on ultrasound and regenerative medicine, followed by presentations at the Latin American Pain Society in Chile and the New York, New Jersey Pain Conference. He mentioned the SoMeDocs online pain conference accessible through nrappain.org, and upcoming ultrasound training sessions in New York City. PRP Epidural Research Review Dr. Rosenblum discussed a randomized control trial involving 30 patients receiving transforaminal epidural injections. The study showed that PRP patients demonstrated significant improvements in leg pain scores at 6, 12, and 24 weeks. He noted that while the study didn't use contrast, he personally prefers using contrast diluted with saline for better visualization. CT-Guided Epidural Study Analysis Dr. Rosenblum reviewed a study comparing CT-guided epidural PRP versus steroid injections, questioning the necessity of CT guidance. The study included 60 patients and showed similar results between PRP and steroid groups at six weeks, though he criticized the short follow-up period, noting that PRP typically takes months to show full effects. Meta-Analysis Discussion Dr. Rosenblum presented a 2025 meta-analysis comparing PRP to steroids in epidural injections. The analysis included 310 patients across five RCTs, demonstrating comparable efficacy between PRP and steroid injections without increased adverse events. He emphasized that his clinical experience shows patients typically require fewer PRP injections compared to steroid treatments. Register for Next Weeks SoMeDocs Pain Conference References Wongjarupong, Asarn, et al. "“Platelet-Rich Plasma” epidural injection an emerging strategy in lumbar disc herniation: a Randomized Controlled Trial." BMC Musculoskeletal Disorders 24.1 (2023): 335. Bise, Sylvain, et al. "Comparison of interlaminar CT-guided epidural platelet-rich plasma versus steroid injection in patients with lumbar radicular pain." European radiology 30 (2020): 3152-3160. Muthu S, Viswanathan VK, Gangadaran P. Is platelet-rich plasma better than steroids as epidural drug of choice in lumbar disc disease with radiculopathy? Meta-analysis of randomized controlled trials. Exp Biol Med (Maywood). 2025 Feb 4;250:10390. doi: 10.3389/ebm.2025.10390. PMID: 39968415; PMCID: PMC11832311.
PRP in the Epidural Space for Radiculopathy Brooklyn Based Pain Physician, David Rosenblum, MD known for his work publishing and teaching Regenerative Pain Medicine and Ultrasound Guided Pain Procedures hosts this podcast covering the latest and most advanced concepts in Pain Medicine. Summary Dr. David Rosenblum delivered a comprehensive lecture covering several key topics in pain management. He discussed his upcoming speaking engagements at PainWeek, ASPN and great upcoming meetings like the Latin American Pain Society, and other conferences. Dr. Rosenblum shared his extensive experience with PRP (Platelet-Rich Plasma) epidural injections, reviewing multiple research studies that support their efficacy. He highlighted three significant studies: a randomized control trial comparing PRP epidural injections to traditional treatments, a CT-guided epidural PRP study, and a 2025 meta-analysis comparing PRP to steroids. Dr. Rosenblum emphasized that PRP treatments are showing comparable or better results than traditional steroid injections, with potentially fewer required treatments and longer-lasting relief. He noted that while PRP is currently not covered by insurance, it represents a growing trend in 'natural' treatment approaches that patients increasingly prefer. Chapters Introduction and Upcoming Events Dr. Rosenblum announced his upcoming lectures at Pain Week focusing on ultrasound and regenerative medicine, followed by presentations at the Latin American Pain Society in Chile and the New York, New Jersey Pain Conference. He mentioned the SoMeDocs online pain conference accessible through nrappain.org, and upcoming ultrasound training sessions in New York City. PRP Epidural Research Review Dr. Rosenblum discussed a randomized control trial involving 30 patients receiving transforaminal epidural injections. The study showed that PRP patients demonstrated significant improvements in leg pain scores at 6, 12, and 24 weeks. He noted that while the study didn't use contrast, he personally prefers using contrast diluted with saline for better visualization. CT-Guided Epidural Study Analysis Dr. Rosenblum reviewed a study comparing CT-guided epidural PRP versus steroid injections, questioning the necessity of CT guidance. The study included 60 patients and showed similar results between PRP and steroid groups at six weeks, though he criticized the short follow-up period, noting that PRP typically takes months to show full effects. Meta-Analysis Discussion Dr. Rosenblum presented a 2025 meta-analysis comparing PRP to steroids in epidural injections. The analysis included 310 patients across five RCTs, demonstrating comparable efficacy between PRP and steroid injections without increased adverse events. He emphasized that his clinical experience shows patients typically require fewer PRP injections compared to steroid treatments. Register for Next Weeks SoMeDocs Pain Conference References Wongjarupong, Asarn, et al. "“Platelet-Rich Plasma” epidural injection an emerging strategy in lumbar disc herniation: a Randomized Controlled Trial." BMC Musculoskeletal Disorders 24.1 (2023): 335. Bise, Sylvain, et al. "Comparison of interlaminar CT-guided epidural platelet-rich plasma versus steroid injection in patients with lumbar radicular pain." European radiology 30 (2020): 3152-3160. Muthu S, Viswanathan VK, Gangadaran P. Is platelet-rich plasma better than steroids as epidural drug of choice in lumbar disc disease with radiculopathy? Meta-analysis of randomized controlled trials. Exp Biol Med (Maywood). 2025 Feb 4;250:10390. doi: 10.3389/ebm.2025.10390. PMID: 39968415; PMCID: PMC11832311.
Summary Dr. David Rosenblum delivered a comprehensive lecture on gender differences in opiate effects and prescribing practices. He discussed several key studies examining how opiates affect males and females differently, both in animal models and humans. Dr. Rosenblum shared findings showing that morphine has stronger analgesic effects in males, while females experience longer-lasting effects. He also addressed racial disparities in opiate prescribing, noting that white patients are more likely to receive opiates. From his personal clinical experience in Brooklyn, Dr. Rosenblum observed that certain populations tend to be at higher risk for opiate abuse. The lecture covered gender-specific risk factors for opiate misuse, with women tending toward emotional/psychological factors and men showing more behavioral issues. Pain Management Board Prep Ultrasound Training REGISTER TODAY! Chapters Introduction and Upcoming Conferences Dr. Rosenblum introduced himself as the host of the Pain Exam Podcast and announced several upcoming conferences including ASPN in July, PainWeek in September, and other events where he will be teaching ultrasound and regenerative medicine. Board Preparation and Opiate Topics Dr. Rosenblum discussed his role in board preparation through painxam.com and nreppain.org. He emphasized that opiates are a frequently tested topic across different board examinations (FIP, ABPM, ABIP, ABA). Gender Differences in Opiate Effects - Animal Studies Dr. Rosenblum presented research showing that in animal studies, morphine exhibited stronger analgesic effects in males, while females showed longer-lasting effects and could tolerate higher doses. He noted that physical dependence was more severe in male rats during spontaneous withdrawal. Racial and Gender Disparities in Opiate Prescribing Dr. Rosenblum discussed a 2025 study revealing racial disparities in opiate prescribing, with white patients more likely to receive opiates. He shared his personal clinical experience in Brooklyn, noting that young white males were often higher-risk for abuse. Gender-Specific Risk Factors for Opiate Misuse Dr. Rosenblum detailed how women tend to show emotional and psychological risk factors for opiate misuse, while men demonstrate more behavioral risk factors. Women were more likely to report distress and past trauma, while men showed higher rates of criminal behavior and substance abuse history. References Djurendic-Brenesel, Maja, et al. "Gender-related differences in the pharmacokinetics of opiates." Forensic science international 194.1-3 (2010): 28-33. Kosten, Thomas R., Bruce J. Rounsaville, and Herbert D. Kleber. "Ethnic and gender differences among opiate addicts." International Journal of the Addictions 20.8 (1985): 1143-1162. Cicero, Theodore J., Shawn C. Aylward, and Edward R. Meyer. "Gender differences in the intravenous self-administration of mu opiate agonists." Pharmacology Biochemistry and Behavior 74.3 (2003): 541-549. Jamison, Robert N., et al. "Gender differences in risk factors for aberrant prescription opioid use." The Journal of Pain 11.4 (2010): 312-320.
Summary Dr. David Rosenblum delivered a comprehensive lecture on gender differences in opiate effects and prescribing practices. He discussed several key studies examining how opiates affect males and females differently, both in animal models and humans. Dr. Rosenblum shared findings showing that morphine has stronger analgesic effects in males, while females experience longer-lasting effects. He also addressed racial disparities in opiate prescribing, noting that white patients are more likely to receive opiates. From his personal clinical experience in Brooklyn, Dr. Rosenblum observed that certain populations tend to be at higher risk for opiate abuse. The lecture covered gender-specific risk factors for opiate misuse, with women tending toward emotional/psychological factors and men showing more behavioral issues. Pain Management Board Prep Ultrasound Training REGISTER TODAY! Chapters Introduction and Upcoming Conferences Dr. Rosenblum introduced himself as the host of the Pain Exam Podcast and announced several upcoming conferences including ASPN in July, PainWeek in September, and other events where he will be teaching ultrasound and regenerative medicine. Board Preparation and Opiate Topics Dr. Rosenblum discussed his role in board preparation through painxam.com and nreppain.org. He emphasized that opiates are a frequently tested topic across different board examinations (FIP, ABPM, ABIP, ABA). Gender Differences in Opiate Effects - Animal Studies Dr. Rosenblum presented research showing that in animal studies, morphine exhibited stronger analgesic effects in males, while females showed longer-lasting effects and could tolerate higher doses. He noted that physical dependence was more severe in male rats during spontaneous withdrawal. Racial and Gender Disparities in Opiate Prescribing Dr. Rosenblum discussed a 2025 study revealing racial disparities in opiate prescribing, with white patients more likely to receive opiates. He shared his personal clinical experience in Brooklyn, noting that young white males were often higher-risk for abuse. Gender-Specific Risk Factors for Opiate Misuse Dr. Rosenblum detailed how women tend to show emotional and psychological risk factors for opiate misuse, while men demonstrate more behavioral risk factors. Women were more likely to report distress and past trauma, while men showed higher rates of criminal behavior and substance abuse history. References Djurendic-Brenesel, Maja, et al. "Gender-related differences in the pharmacokinetics of opiates." Forensic science international 194.1-3 (2010): 28-33. Kosten, Thomas R., Bruce J. Rounsaville, and Herbert D. Kleber. "Ethnic and gender differences among opiate addicts." International Journal of the Addictions 20.8 (1985): 1143-1162. Cicero, Theodore J., Shawn C. Aylward, and Edward R. Meyer. "Gender differences in the intravenous self-administration of mu opiate agonists." Pharmacology Biochemistry and Behavior 74.3 (2003): 541-549. Jamison, Robert N., et al. "Gender differences in risk factors for aberrant prescription opioid use." The Journal of Pain 11.4 (2010): 312-320.
Summary Dr. David Rosenblum delivered a comprehensive lecture on gender differences in opiate effects and prescribing practices. He discussed several key studies examining how opiates affect males and females differently, both in animal models and humans. Dr. Rosenblum shared findings showing that morphine has stronger analgesic effects in males, while females experience longer-lasting effects. He also addressed racial disparities in opiate prescribing, noting that white patients are more likely to receive opiates. From his personal clinical experience in Brooklyn, Dr. Rosenblum observed that certain populations tend to be at higher risk for opiate abuse. The lecture covered gender-specific risk factors for opiate misuse, with women tending toward emotional/psychological factors and men showing more behavioral issues. Pain Management Board Prep Ultrasound Training REGISTER TODAY! Chapters Introduction and Upcoming Conferences Dr. Rosenblum introduced himself as the host of the Pain Exam Podcast and announced several upcoming conferences including ASPN in July, PainWeek in September, and other events where he will be teaching ultrasound and regenerative medicine. Board Preparation and Opiate Topics Dr. Rosenblum discussed his role in board preparation through painxam.com and nreppain.org. He emphasized that opiates are a frequently tested topic across different board examinations (FIP, ABPM, ABIP, ABA). Gender Differences in Opiate Effects - Animal Studies Dr. Rosenblum presented research showing that in animal studies, morphine exhibited stronger analgesic effects in males, while females showed longer-lasting effects and could tolerate higher doses. He noted that physical dependence was more severe in male rats during spontaneous withdrawal. Racial and Gender Disparities in Opiate Prescribing Dr. Rosenblum discussed a 2025 study revealing racial disparities in opiate prescribing, with white patients more likely to receive opiates. He shared his personal clinical experience in Brooklyn, noting that young white males were often higher-risk for abuse. Gender-Specific Risk Factors for Opiate Misuse Dr. Rosenblum detailed how women tend to show emotional and psychological risk factors for opiate misuse, while men demonstrate more behavioral risk factors. Women were more likely to report distress and past trauma, while men showed higher rates of criminal behavior and substance abuse history. References Djurendic-Brenesel, Maja, et al. "Gender-related differences in the pharmacokinetics of opiates." Forensic science international 194.1-3 (2010): 28-33. Kosten, Thomas R., Bruce J. Rounsaville, and Herbert D. Kleber. "Ethnic and gender differences among opiate addicts." International Journal of the Addictions 20.8 (1985): 1143-1162. Cicero, Theodore J., Shawn C. Aylward, and Edward R. Meyer. "Gender differences in the intravenous self-administration of mu opiate agonists." Pharmacology Biochemistry and Behavior 74.3 (2003): 541-549. Jamison, Robert N., et al. "Gender differences in risk factors for aberrant prescription opioid use." The Journal of Pain 11.4 (2010): 312-320.
Summary At some point this medication may show its face on the pain boards. Whether or not Suzetrigine will appear on the pain boards, all of us need to know about this new class of analgesic. Brought to you by NRAP Academy, home of the PainExam Board Prep Here, Dr. David Rosenblum delivered a comprehensive lecture about a new pain medication called Journavx (Suzetrigine). He discussed its mechanism of action as a NAV 1.8 receptor inhibitor, its clinical applications, contraindications, and dosing guidelines. Dr. Rosenblum emphasized that this non-opioid medication represents a new class of pain management drugs with no addiction potential. He also shared information about upcoming educational events, including ultrasound courses and various pain management conferences. The lecture included detailed information about drug interactions, safety considerations, and clinical trial results comparing Journavx to placebo and hydrocodone-acetaminophen combinations. Key findings from clinical trials showed that Jornavix achieved pain relief in 119 minutes compared to 480 minutes for placebo in abdominoplasty trials, and 240 minutes versus 480 minutes in bunionectomy trials. The recommended dosing is 50mg tablets twice daily, with an initial loading dose of 100mg. While the drug showed promising results for moderate to severe acute pain management, it did not demonstrate superiority over hydrocodone in clinical trials. Important contraindications include CYP3A inhibitors, and special considerations are needed for patients with hepatic impairment or those taking hormonal contraceptives. The medication should be taken on an empty stomach, either one hour before or two hours after food, and patients should avoid grapefruit juice while on this medication. For more infomation.... Chapters Introduction and Upcoming Events Dr. Rosenblum announced several upcoming events, including an ultrasound course in New York City on May 17th, 2025. He mentioned offering ultrasound and IV training for healthcare professionals, particularly nurses, ICUs, PAs, and hospital doctors. He also highlighted upcoming conferences including ASPN, Pain Week, Latin American Pain Society, New York, New Jersey Pain Congress, ASIPP, and EPA. Introduction to Journavx (Suzetrigine) Dr. Rosenblum introduced Suzetrigine (Journavx), a new 50mg tablet medication. He emphasized that this discussion was not sponsored by any pharmaceutical company but rather focused on educating about a new class of pain medication. He noted its potential importance as a future board examination topic. Mechanism of Action Dr. Rosenblum explained that Jornavx works by inhibiting the NAV 1.8 receptor. He detailed how the drug blocks sodium ions from entering pain-sensing neurons, disrupting action potential initiation and propagation. He emphasized that the drug is highly selective, binding over 31,000 times more selectively to NAV 1.8 than other NAV subtypes. Contraindications and Drug Interactions Dr. Rosenblum outlined various contraindications, particularly focusing on CYP3A inhibitors and inducers. He listed specific medications in each category and emphasized the importance of careful monitoring when prescribing Journavx alongside these medications. Clinical Trial Results and Dosing Guidelines Dr. Rosenblum presented clinical trial results showing Journavx's effectiveness in treating moderate to severe acute pain. He detailed the dosing guidelines: 50mg tablets twice daily, with an initial loading dose of 100mg. He emphasized the importance of taking the medication on an empty stomach and avoiding grapefruit juice. Q&A No Q&A session in this lecture
Summary At some point this medication may show its face on the Anesthesia boards. Whether or not Suzetrigine will appear on the Anesthesiology boards, all of us need to know about this new class of analgesic. Brought to you by NRAP Academy, home of the AnesthesiaExam Board Prep Here, Dr. David Rosenblum delivered a comprehensive lecture about a new pain medication called Journavx (Suzetrigine). He discussed its mechanism of action as a NAV 1.8 receptor inhibitor, its clinical applications, contraindications, and dosing guidelines. Dr. Rosenblum emphasized that this non-opioid medication represents a new class of pain management drugs with no addiction potential. He also shared information about upcoming educational events, including ultrasound courses and various pain management conferences. The lecture included detailed information about drug interactions, safety considerations, and clinical trial results comparing Journavx to placebo and hydrocodone-acetaminophen combinations. Key findings from clinical trials showed that Jornavix achieved pain relief in 119 minutes compared to 480 minutes for placebo in abdominoplasty trials, and 240 minutes versus 480 minutes in bunionectomy trials. The recommended dosing is 50mg tablets twice daily, with an initial loading dose of 100mg. While the drug showed promising results for moderate to severe acute pain management, it did not demonstrate superiority over hydrocodone in clinical trials. Important contraindications include CYP3A inhibitors, and special considerations are needed for patients with hepatic impairment or those taking hormonal contraceptives. The medication should be taken on an empty stomach, either one hour before or two hours after food, and patients should avoid grapefruit juice while on this medication. For more infomation.... Chapters Introduction and Upcoming Events Dr. Rosenblum announced several upcoming events, including an ultrasound course in New York City on May 17th, 2025. He mentioned offering ultrasound and IV training for healthcare professionals, particularly nurses, ICUs, PAs, and hospital doctors. He also highlighted upcoming conferences including ASPN, Pain Week, Latin American Pain Society, New York, New Jersey Pain Congress, ASIPP, and EPA. Introduction to Journavx (Suzetrigine) Dr. Rosenblum introduced Suzetrigine (Journavx), a new 50mg tablet medication. He emphasized that this discussion was not sponsored by any pharmaceutical company but rather focused on educating about a new class of pain medication. He noted its potential importance as a future board examination topic. Mechanism of Action Dr. Rosenblum explained that Jornavx works by inhibiting the NAV 1.8 receptor. He detailed how the drug blocks sodium ions from entering pain-sensing neurons, disrupting action potential initiation and propagation. He emphasized that the drug is highly selective, binding over 31,000 times more selectively to NAV 1.8 than other NAV subtypes. Contraindications and Drug Interactions Dr. Rosenblum outlined various contraindications, particularly focusing on CYP3A inhibitors and inducers. He listed specific medications in each category and emphasized the importance of careful monitoring when prescribing Journavx alongside these medications. Clinical Trial Results and Dosing Guidelines Dr. Rosenblum presented clinical trial results showing Journavx's effectiveness in treating moderate to severe acute pain. He detailed the dosing guidelines: 50mg tablets twice daily, with an initial loading dose of 100mg. He emphasized the importance of taking the medication on an empty stomach and avoiding grapefruit juice. Q&A No Q&A session in this lecture
Summary At some point this medication may show its face on the Physiatry boards. Whether or not Suzetrigine will appear on the Physical Medicine and Rehabilitation boards, all of us need to know about this new class of analgesic. Brought to you by NRAP Academy, home of the PMRExam Board Prep Here, Dr. David Rosenblum delivered a comprehensive lecture about a new pain medication called Journavx (Suzetrigine). He discussed its mechanism of action as a NAV 1.8 receptor inhibitor, its clinical applications, contraindications, and dosing guidelines. Dr. Rosenblum emphasized that this non-opioid medication represents a new class of pain management drugs with no addiction potential. He also shared information about upcoming educational events, including ultrasound courses and various pain management conferences. The lecture included detailed information about drug interactions, safety considerations, and clinical trial results comparing Journavx to placebo and hydrocodone-acetaminophen combinations. Key findings from clinical trials showed that Jornavix achieved pain relief in 119 minutes compared to 480 minutes for placebo in abdominoplasty trials, and 240 minutes versus 480 minutes in bunionectomy trials. The recommended dosing is 50mg tablets twice daily, with an initial loading dose of 100mg. While the drug showed promising results for moderate to severe acute pain management, it did not demonstrate superiority over hydrocodone in clinical trials. Important contraindications include CYP3A inhibitors, and special considerations are needed for patients with hepatic impairment or those taking hormonal contraceptives. The medication should be taken on an empty stomach, either one hour before or two hours after food, and patients should avoid grapefruit juice while on this medication. For more infomation.... Chapters Introduction and Upcoming Events Dr. Rosenblum announced several upcoming events, including an ultrasound course in New York City on May 17th, 2025. He mentioned offering ultrasound and IV training for healthcare professionals, particularly nurses, ICUs, PAs, and hospital doctors. He also highlighted upcoming conferences including ASPN, Pain Week, Latin American Pain Society, New York, New Jersey Pain Congress, ASIPP, and EPA. Introduction to Journavx (Suzetrigine) Dr. Rosenblum introduced Suzetrigine (Journavx), a new 50mg tablet medication. He emphasized that this discussion was not sponsored by any pharmaceutical company but rather focused on educating about a new class of pain medication. He noted its potential importance as a future board examination topic. Mechanism of Action Dr. Rosenblum explained that Jornavx works by inhibiting the NAV 1.8 receptor. He detailed how the drug blocks sodium ions from entering pain-sensing neurons, disrupting action potential initiation and propagation. He emphasized that the drug is highly selective, binding over 31,000 times more selectively to NAV 1.8 than other NAV subtypes. Contraindications and Drug Interactions Dr. Rosenblum outlined various contraindications, particularly focusing on CYP3A inhibitors and inducers. He listed specific medications in each category and emphasized the importance of careful monitoring when prescribing Journavx alongside these medications. Clinical Trial Results and Dosing Guidelines Dr. Rosenblum presented clinical trial results showing Journavx's effectiveness in treating moderate to severe acute pain. He detailed the dosing guidelines: 50mg tablets twice daily, with an initial loading dose of 100mg. He emphasized the importance of taking the medication on an empty stomach and avoiding grapefruit juice. Q&A No Q&A session in this lecture
In this episode we discussed the latest updates on the coding and reimbursement for SIJ Fusion. Our guest, Dr. Douglas Beall, talked about his experience with the different approaches of SIJ fusion therapies. We also discussed where the SIJ fusion space may be headed in the future. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Douglas Beall, MD: Dr. Beall attended medical school at Georgetown University School of Medicine in Washington, DC, and completed his residency at The Johns Hopkins Hospital in Baltimore, Maryland. Following residency, he was Chief of Interventional Services at Sheppard Air Force Base in Wichita Falls, Texas. He then completed a fellowship in Musculoskeletal Radiology at Mayo Clinic in Rochester, Minnesota, where he was trained in interventional spine techniques before returning to the US Air Force as Division Chief of Musculoskeletal Radiology. Following his service as a Major in the US Air Force Dr. Beall was chief of Musculoskeletal Radiology and Fellowship Director at the University of Oklahoma prior to entering private practice as the Chief of Services. http://drdouglasbeall.com/ About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Saluda Medical: Saluda is the first to directly measure the spinal cord's physiologic response to stimulation. A 10+ year journey since the first ECAP measurement to transform the science and practice of SCS using Evoked Compound Action Potentials (ECAPs) to pioneer smart neuromodulation therapy. The Evoke® System listens and responds to each patient's neural signature. https://www.saludamedical.com/
Summary The video covers a conversation between Dr. David Rosenblum and Dr. Hamed Sadeghipour, discussing board preparation experiences and the current state of pain management practice. Dr. Rosenblum begins by announcing upcoming events, including a May 17th ultrasound course in New York City and his lectures at various conferences. He also mentions shadowing opportunities at his office. Dr. Sadeghipour shares his board preparation experience, discussing three main resources he used: Huntoon book (800 questions), Board Vitals (700 questions), and Pain Exam. He achieved notably high scores using these resources. Regarding his current practice, Dr. Sadeghipour describes working both in academic anesthesia (40-50% time) and private pain practice, managing four offices with four nurse practitioners. The discussion then shifts to the changing landscape of pain management, with both doctors noting concerning trends: increasing focus on surgery center procedures over office-based ones due to reimbursement differences, the challenge of maintaining competency in advanced procedures, and competition from non-specialists entering the field. They also discuss the future of the specialty, suggesting it's moving toward becoming a hybrid of neurosurgery and orthopedic surgery with traditional pain management procedures. For pain medicine Board Prep go to NRAPpain.org For ultraound training go to NRAP Academy Highlights Introduction and Upcoming Events Dr. Rosenblum introduces the podcast and announces several upcoming events, including an ultrasound course in New York City on May 17th, appearances at ASPN and Pain Week conferences, and opportunities for shadowing at his practice. Board Preparation Experience Discussion Dr. Sadeghipour details his board preparation strategy using three main resources: Huntoon book (800 questions), Board Vitals (700 questions), and Pain Exam(700 questions videos, lectures, ultrasound training, regenerative medicine training and more). He explains the strengths and limitations of each resource and mentions achieving exceptionally high scores. Current Practice Structure Dr. Sadeghipour describes his dual practice model: Evolution of Pain Management Practice Both doctors discuss the shifting landscape of pain management, noting increased focus on surgery center procedures, reimbursement challenges, and competition from non-specialists. They address concerns about fellowship training adequacy and the financial pressures affecting new practitioners. Future of Pain Management Specialty The discussion concludes with perspectives on the specialty's future, suggesting it's evolving toward a combination of minimally invasive spine surgery and traditional pain management, with concerns about maintaining specialty integrity and the need for stronger regulatory oversight.
Summary The video covers a conversation between Dr. David Rosenblum and Dr. Hamed Sadeghipour, discussing board preparation experiences and the current state of pain management practice. Dr. Rosenblum begins by announcing upcoming events, including a May 17th ultrasound course in New York City and his lectures at various conferences. He also mentions shadowing opportunities at his office. Dr. Sadeghipour shares his board preparation experience, discussing three main resources he used: Huntoon book (800 questions), Board Vitals (700 questions), and Pain Exam. He achieved notably high scores using these resources. Regarding his current practice, Dr. Sadeghipour describes working both in academic anesthesia (40-50% time) and private pain practice, managing four offices with four nurse practitioners The discussion then shifts to the changing landscape of pain management, with both doctors noting concerning trends: increasing focus on surgery center procedures over office-based ones due to reimbursement differences, the challenge of maintaining competency in advanced procedures, and competition from non-specialists entering the field. They also discuss the future of the specialty, suggesting it's moving toward becoming a hybrid of neurosurgery and orthopedic surgery with traditional pain management procedures. For pain medicine Board Prep go to NRAPpain.org For ultraound training go to NRAP Academy Highlights Introduction and Upcoming Events Dr. Rosenblum introduces the podcast and announces several upcoming events, including an ultrasound course in New York City on May 17th, appearances at ASPN and Pain Week conferences, and opportunities for shadowing at his practice. Board Preparation Experience Discussion Dr. Sadeghipour details his board preparation strategy using three main resources: Huntoon book (800 questions), Board Vitals (700 questions), and Pain Exam(700 questions videos, lectures, ultrasound training, regenerative medicine training and more). He explains the strengths and limitations of each resource and mentions achieving exceptionally high scores. Current Practice Structure Dr. Sadeghipour describes his dual practice model: Evolution of Pain Management Practice Both doctors discuss the shifting landscape of pain management, noting increased focus on surgery center procedures, reimbursement challenges, and competition from non-specialists. They address concerns about fellowship training adequacy and the financial pressures affecting new practitioners. Future of Pain Management Specialty The discussion concludes with perspectives on the specialty's future, suggesting it's evolving toward a combination of minimally invasive spine surgery and traditional pain management, with concerns about maintaining specialty integrity and the need for stronger regulatory oversight.
Summary The video covers a conversation between Dr. David Rosenblum and Dr. Hamed Sadeghipour, discussing board preparation experiences and the current state of pain management practice. Dr. Rosenblum begins by announcing upcoming events, including a May 17th ultrasound course in New York City and his lectures at various conferences. He also mentions shadowing opportunities at his office. Dr. Sadeghipour shares his board preparation experience, discussing three main resources he used: Huntoon book (800 questions), Board Vitals (700 questions), and Pain Exam. He achieved notably high scores using these resources. Regarding his current practice, Dr. Sadeghipour describes working both in academic anesthesia (40-50% time) and private pain practice, managing four offices with four nurse practitioners. The discussion then shifts to the changing landscape of pain management, with both doctors noting concerning trends: increasing focus on surgery center procedures over office-based ones due to reimbursement differences, the challenge of maintaining competency in advanced procedures, and competition from non-specialists entering the field. They also discuss the future of the specialty, suggesting it's moving toward becoming a hybrid of neurosurgery and orthopedic surgery with traditional pain management procedures. For pain medicine Board Prep go to NRAPpain.org For ultraound training go to NRAP Academy Highlights Introduction and Upcoming Events Dr. Rosenblum introduces the podcast and announces several upcoming events, including an ultrasound course in New York City on May 17th, appearances at ASPN and Pain Week conferences, and opportunities for shadowing at his practice. Board Preparation Experience Discussion Dr. Sadeghipour details his board preparation strategy using three main resources: Huntoon book (800 questions), Board Vitals (700 questions), and Pain Exam(700 questions videos, lectures, ultrasound training, regenerative medicine training and more). He explains the strengths and limitations of each resource and mentions achieving exceptionally high scores. Current Practice Structure Dr. Sadeghipour describes his dual practice model: Evolution of Pain Management Practice Both doctors discuss the shifting landscape of pain management, noting increased focus on surgery center procedures, reimbursement challenges, and competition from non-specialists. They address concerns about fellowship training adequacy and the financial pressures affecting new practitioners. Future of Pain Management Specialty The discussion concludes with perspectives on the specialty's future, suggesting it's evolving toward a combination of minimally invasive spine surgery and traditional pain management, with concerns about maintaining specialty integrity and the need for stronger regulatory oversight.
In this episode we discussed the advances in the lateral approach for sacroiliac joint fusion. Our guests, Dr. Usman Latif talked about his experience in the research and development of Liberty SI. We also discussed the most updated data on lateral SIJ fusion and how Dr. Latif decides which approach to use for his patients. Full Disclosure: Dr. Latif is a consultant of Spinal Simplicity. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Usman Latif, MD: Dr. Latif is certified by the American Board of Anesthesiology with a subcertification in pain management. He completed a fellowship at Massachusetts General Hospital. He earned his medical degree from the University of Kansas School of Medicine and completed his residency at Wake Forest University Medical Center About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Saluda Medical: Saluda is the first to directly measure the spinal cord's physiologic response to stimulation. A 10+ year journey since the first ECAP measurement to transform the science and practice of SCS using Evoked Compound Action Potentials (ECAPs) to pioneer smart neuromodulation therapy. The Evoke® System listens and responds to each patient's neural signature. https://www.saludamedical.com/ Nalu Medical: Nalu Offers a Long-Term Solution For Pain. More than just new technology; it's a whole new world of opportunities. https://nalumed.com/ Medtronic: Medtronic leads global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. https://www.medtronic.com/us-en/patients/treatments-therapies/pain.html Spinal Simplicity: Spinal Simplicity is a Healthcare Technology company dedicated to creating simple, innovative procedure solutions for our physician partners to help improve their patient's pain and quality of life. We believe strongly in AO orthopedic principles of Early & Safe Mobilization, Bone Decortication, Joint Stability and Anatomy Restoration. Our brands include Minuteman, Liberty-SI, Patriot-SI and Hero-SI. https://spinalsimplicity.com/
In this episode we discussed the differences between physiological closed loop spinal cord stimulation and traditional stimulation. Our guests, Dr. Jason Pope and Dr. Johnathan Goree talked about the data behind Saluda's closed loop stimulation and how it differs with Medtronic's therapy. They also discussed knowing and controlling the dose of stimulation and what they think the future is for this therapy. Full Disclosure: Dr. Pope and Dr. Goree are consultants of Saluda Medical. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Jason Pope, MD: With over a decade of experience, and regarded as one of the most influential key opinion leaders in the field of pain medicine and neuromodulation, Dr. Jason Pope in Santa Rosa is triple boarded in Pain Medicine, has published over 80 peer reviewed journals, spoken at numerous national and international conferences, and has consulted with many start-ups and established companies. https://evolverestorativecenter.care/ Guest, Jonathan Goree, MD: Board certified in anesthesiology and pain medicine, Dr. Johnathan Goree is a proud alumnus of Catholic High School in Little Rock, Arkansas. In 2014, Dr. Goree returned home to Little Rock, Arkansas to join the faculty at UAMS where he serves as the Director of Interventional Pain Management Services and an Assistant Professor in the Department of Anesthesiology. He primarily focuses on the treatment of chronic pain conditions using minimally invasive procedures, spinal cord stimulation, and vertebral augmentation. https://medicine.uams.edu/pain/meet-our-team/johnathan-h-goree-m-d/ About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Saluda Medical: Saluda is the first to directly measure the spinal cord's physiologic response to stimulation. A 10+ year journey since the first ECAP measurement to transform the science and practice of SCS using Evoked Compound Action Potentials (ECAPs) to pioneer smart neuromodulation therapy. The Evoke® System listens and responds to each patient's neural signature. https://www.saludamedical.com/ Nalu Medical: Nalu Offers a Long-Term Solution For Pain. More than just new technology; it's a whole new world of opportunities. https://nalumed.com/ Medtronic: Medtronic leads global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. https://www.medtronic.com/us-en/patients/treatments-therapies/pain.html Spinal Simplicity: Spinal Simplicity is a Healthcare Technology company dedicated to creating simple, innovative procedure solutions for our physician partners to help improve their patient's pain and quality of life. We believe strongly in AO orthopedic principles of Early & Safe Mobilization, Bone Decortication, Joint Stability and Anatomy Restoration. Our brands include Minuteman, Liberty-SI, Patriot-SI and Hero-SI. https://spinalsimplicity.com/
In this episode we discussed the roles advanced practice providers (APPs) play in the interventional pain practice. Our guests, Ashley Comer, Casey Grillo, and Morteza Rabii talked about how to approach minimally invasive procedures in their practice. They also discussed how to partner with industry. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Ashley Comer: Ashley is a Board Certified Nurse Practitioner, who is certified by the American Academy of Nurse Practitioners. Born and raised in Charleston, West Virginia, Ashley attended West Virginia State University Community and Technical College where she obtained her Associate's Degree in Nursing. Continuing her education, she went on to receive her Bachelor of Science in Nursing from West Virginia University. https://centerforpainrelief.com/ashley-comer-np/ Guest, Casey Grillo: Casey is a Nurse Practitioner at The Spine & Pain Institute of NY and has recently transitioned into the role of Lead Advanced Practice provider for the practice. She collaborates with her physicians, managing and educating patients of all ages with chronic pain. Casey received her Bachelor's degree in Nursing from Seton Hall University and a Master's degree in Science of Nursing from Wagner College. She is currently a member of the Nurse Practitioner Association of NYS. https://spinepainny.com/casey-grillo/ Guest, Morteza Rabii: Morteza earned his Bachelor of Science in Nursing and Doctor of Nursing Practice as a Nurse Practitioner from the University of Kansas. In graduate school he focused on the importance of patient education on improving pain relief. Prior to joining Crimson Pain Management, Mort worked in orthopedics for nearly 10 years, gaining an understanding of chronic back and joint pain. https://crimsonpainmanagement.com/about/ About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Saluda Medical: Saluda is the first to directly measure the spinal cord's physiologic response to stimulation. A 10+ year journey since the first ECAP measurement to transform the science and practice of SCS using Evoked Compound Action Potentials (ECAPs) to pioneer smart neuromodulation therapy. The Evoke® System listens and responds to each patient's neural signature. https://www.saludamedical.com/ Nalu Medical: Nalu Offers a Long-Term Solution For Pain. More than just new technology; it's a whole new world of opportunities. https://nalumed.com/ Medtronic: Medtronic leads global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. https://www.medtronic.com/us-en/patients/treatments-therapies/pain.html Spinal Simplicity: Spinal Simplicity is a Healthcare Technology company dedicated to creating simple, innovative procedure solutions for our physician partners to help improve their patient's pain and quality of life. We believe strongly in AO orthopedic principles of Early & Safe Mobilization, Bone Decortication, Joint Stability and Anatomy Restoration. Our brands include Minuteman, Liberty-SI, Patriot-SI and Hero-SI. https://spinalsimplicity.com/
In this episode we discussed the current state of healthcare fraud. Our guest, Ronald Chapman, discussed federal cases involving pain management providers. He provided the DO's and DONT's for healthcare providers to be compliant within the current healthcare landscape. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Ronald Chapman: Mr. Chapman is a healthcare defense attorney and President of CCG Healthcare. He has secured multiple acquittals for pain management providers accused of healthcare fraud. https://bio.site/ronald_chapman www.ccghealthcare.com About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Saluda Medical: Saluda is the first to directly measure the spinal cord's physiologic response to stimulation. A 10+ year journey since the first ECAP measurement to transform the science and practice of SCS using Evoked Compound Action Potentials (ECAPs) to pioneer smart neuromodulation therapy. The Evoke® System listens and responds to each patient's neural signature. https://www.saludamedical.com/ Nalu Medical: Nalu Offers a Long-Term Solution For Pain. More than just new technology; it's a whole new world of opportunities. https://nalumed.com/ Medtronic: Medtronic leads global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. https://www.medtronic.com/us-en/patients/treatments-therapies/pain.html Spinal Simplicity: Spinal Simplicity is a Healthcare Technology company dedicated to creating simple, innovative procedure solutions for our physician partners to help improve their patient's pain and quality of life. We believe strongly in AO orthopedic principles of Early & Safe Mobilization, Bone Decortication, Joint Stability and Anatomy Restoration. Our brands include Minuteman, Liberty-SI, Patriot-SI and Hero-SI. https://spinalsimplicity.com/
In this episode we reflected on the huge success of this past ASPN annual meeting. We talked about the newest section in ASPN: Health and Wellness. Our guest, Matt Dixon, discussed the elite challenges that time starved health care providers face and gave his professional advice on how to face them. He also talked about how to manage stress, create a winning team culture, and many more pearls to make a better you. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Matt Dixon: Matt Dixon is a world-class triathlon coach, former professional triathlete and elite swimmer, and an exercise physiologist. Under his guidance, Purple Patch athletes have recorded over 350 professional IRONMAN and IRONMAN 70.3 victories and podiums, including multiple world championships. His distinct performance methodology focused on integrating performance into time-starved life has made him a highly sought after resource for many industry leading CEOs and executives. Matt is the author of The Well-Built Triathlete and Fast-Track Triathlete, a regular contributor to sports magazines and publications, an IRONMAN U master coach, and a corporate speaker to major companies on performance and leadership. https://www.purplepatchfitness.com/ About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Saluda Medical: Saluda is the first to directly measure the spinal cord's physiologic response to stimulation. A 10+ year journey since the first ECAP measurement to transform the science and practice of SCS using Evoked Compound Action Potentials (ECAPs) to pioneer smart neuromodulation therapy. The Evoke® System listens and responds to each patient's neural signature. https://www.saludamedical.com/ Nalu Medical: Nalu Offers a Long-Term Solution For Pain. More than just new technology; it's a whole new world of opportunities. https://nalumed.com/ Medtronic: Medtronic leads global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. https://www.medtronic.com/us-en/patients/treatments-therapies/pain.html Spinal Simplicity: Spinal Simplicity is a Healthcare Technology company dedicated to creating simple, innovative procedure solutions for our physician partners to help improve their patient's pain and quality of life. We believe strongly in AO orthopedic principles of Early & Safe Mobilization, Bone Decortication, Joint Stability and Anatomy Restoration. Our brands include Minuteman, Liberty-SI, Patriot-SI and Hero-SI. https://spinalsimplicity.com/
What does it take to build a personal brand in the medical field? In this episode, Dr. Patrick Buchanan, Interventional Pain Management Physician and Co-Host of the Pain Unfiltered Podcast, shares his insights with us live from the ASPN conference. Dr. Buchanan will explain the importance of personal branding and how it has shaped his career decisions. Learn more: https://apmsuccess.com/244 Watch the video: https://apmsuccess.com/244v Need help with wealth management? Learn about APM Wealth's process, here: https://apm-wealth.com/services. Or, get our free guide explaining some of our key methods for building wealth with clients: https://apm-wealth.com/freedom Or check out our webinar for helping practice owners optimize wealth building: www.apm-wealth.com/webinar
What are the biggest challenges facing pain specialists today? In this episode, Dr. Krishnan Chakravarthy, Physician Scientist, Engineer, and President and Co-Founder of Solaris Research Institute, joins us to discuss the pressing issues that have captured the attention of the American Society of Pain and Neuroscience (ASPN). Dr. Chakravarthy explores the future of pain specialist education, effective training methods for clinicians, and the importance of adopting specific therapy guidelines backed by robust evidence. Learn more: https://apmsuccess.com/242Watch the video: https://apmsuccess.com/242v Need help with wealth management? Learn about APM Wealth's process, here: https://apm-wealth.com/services. Or, get our free guide explaining some of our key methods for building wealth with clients: https://apm-wealth.com/freedom Or check out our webinar for helping practice owners optimize wealth building: www.apm-wealth.com/webinar
In this episode, we dive into a small company called Aspen AeroGels, a company at the crossroads of advanced thermal insulation and electric vehicle battery technology. Learn about the company's position in preventing thermal runaway in EV batteries, and their expanding role in energy and industrial sectors and why this position makes for a possible small-cap investment in our portfolio. We take a look at Aspen AeroGel's financial outlook, competition, and the challenges they face in scaling their manufacturing capabilities. Subscribe and join us on Discord for in-depth discussions and exclusive content!
In this episode we discussed the importance of closed loop spinal cord stimulation therapy with Dr. Krishnan Chakravarthy and Dr. Nomen Azeem. We reviewed the data behind Medtronic's Inceptiv closed loop therapy as well as current studies that are ongoing. We discussed what makes this closed loop therapy unique and what the future holds. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Krishnan Chakravarthy MD: Dr. Chakravarthy is an anesthesiologist who specializes in multi-modal pain management. He currently serves on the editorial board of several national and international peer-reviewed journals, and committees on organizations such as the International Neuromodulation Society, and American Society of Pain and Neuroscience. An entrepreneur, Dr. Chakravarthy is a founder of several biotechnology startup companies focusing on applications of nanotechnology in the pain space, and novel small molecule therapeutic development to advance pain care. https://solarisresearchinstitute.squarespace.com/ Guest, Dr. Nomen Azeem MD: Dr. Nomen Azeem, an internationally recognized Interventional Pain Management physician, Founder and CEO of Florida Spine and Pain Specialists, brings a wealth of expertise and dedication to the field of pain management, with a commitment to advancing patient care and research initiatives. https://www.flsps.com/ About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Saluda Medical: Saluda is the first to directly measure the spinal cord's physiologic response to stimulation. A 10+ year journey since the first ECAP measurement to transform the science and practice of SCS using Evoked Compound Action Potentials (ECAPs) to pioneer smart neuromodulation therapy. The Evoke® System listens and responds to each patient's neural signature. https://www.saludamedical.com/ Nalu Medical: Nalu Offers a Long-Term Solution For Pain. More than just new technology; it's a whole new world of opportunities. https://nalumed.com/ Medtronic: Medtronic leads global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. https://www.medtronic.com/us-en/patients/treatments-therapies/pain.html Spinal Simplicity: Spinal Simplicity is a Healthcare Technology company dedicated to creating simple, innovative procedure solutions for our physician partners to help improve their patient's pain and quality of life. We believe strongly in AO orthopedic principles of Early & Safe Mobilization, Bone Decortication, Joint Stability and Anatomy Restoration. Our brands include Minuteman, Liberty-SI, Patriot-SI and Hero-SI. https://spinalsimplicity.com/
Tom Russell "Honky Jazz" - Hotwalker www.tomrussell.com Tenderhooks "Prelude in New York" - North Star Tenderhooks "June On The Moon" facebook.com/tenderhooks Marianne Kesler "June" Marianne Kesler "Green Room" www.mariannekesler.com ************ Sad Films "Past Tense" - Exchange Pleasantries www.sadfilms.co.uk Bud Rokesky “Tell John” – Outsider www.budrokeksy.com John Shipe "Unfinished Business" - Water This Dark www.johnshipe.com Julian Taylor "Running Away" - Pathways www.juliantaylormusic.ca Paul Thompson "Baby Hedgehog" - Baby Hedgehog https://paulsmusic.co.uk/ Stella Prince "What's Mine" - Dear Future Me www.stellaprincemmusic.comm Joy Zimmerman "I Stand Corrected" - Where The Light Lives www.joyzimmermanmusic.com *************** ALBUM FOCUS Putumayo World Music presents "African Celebration" with 10 songwriters from and with ties to the African continent. www.putumayo.com Assol Garcia (Cabo Verde) "Txuska" Moussa Koita (Burkina Faso) "Ouaga-Bobo" Ashimba (Tanzania) "Afrika" ************************ Thomas Nicholas Band "Wrong Side" - We're Gonna Be Okay www.tinband.com MEST "When We Were Young" - Youth www.mestmusic.com Rose Haze "Heaven Or Las Vegas" www.rosehaze.com Aspn "Rumours" - In This Dream https://aspn.band/ The Veldt "CCCP" - Illuminated 1989 www.facebook.com/veldtthe Jack's Saving Grace "Unsigned" www.jackssavinggrace.com Ear Ringers "Pretty Pictures" www.facebook.com/earringers --- Send in a voice message: https://podcasters.spotify.com/pod/show/radiocblue/message Support this podcast: https://podcasters.spotify.com/pod/show/radiocblue/support
In this episode we discussed the state peripheral nerve stimulation with Dr. Mehul Desai. Dr. Timothy Deer talked about the history of peripheral nerve stimulation and how far its come. We then discussed the current data and rising indications to treat different pain generators. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Mehul Desai MD: Dr. Desai is board certified in Physical Medicine and Rehabilitation and Pain Medicine. He specializes in the use of cutting edge technologies for the treatment of musculoskeletal pain and disease. https://www.isppcenter.com/provider/mehul-j-desai-md-mph Guest, Dr. Morad Nasseri MD: Dr. Nasseri is board certified in Neurology. He completed his Pain Fellowship at Wayne State University. https://www.synergexmed.com/providers/pain-management/dr-morad-nasseri/ About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Saluda Medical: Saluda is the first to directly measure the spinal cord's physiologic response to stimulation. A 10+ year journey since the first ECAP measurement to transform the science and practice of SCS using Evoked Compound Action Potentials (ECAPs) to pioneer smart neuromodulation therapy. The Evoke® System listens and responds to each patient's neural signature. https://www.saludamedical.com/ Nalu Medical: Nalu Offers a Long-Term Solution For Pain. More than just new technology; it's a whole new world of opportunities. https://nalumed.com/ Medtronic https://www.medtronic.com/us-en/patients/treatments-therapies/pain.html
In this episode we took a deeper dive into 2 of ASPN's stars, Dr. Jordan Tate and Dr. Alexa Moreira. We discussed the current state of women in medicine and talked about the female mentorship program. We also discussed the poster to podium program and some tips to become an attractive fellowship candidate. We had our first APSN member, Dr. Tolga Suvar, ask a few questions to the guests. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Dr. Jordan Tate MD: Dr. Tate is a double board-certified pain medicine and physical medicine and rehabilitation specialist at Southern Pain and Spine in Jasper, Georgia. She is the Chair of the Diversity/Inclusion Committee and editor of the ASPN newsletter. https://www.southernpainandspine.com/md/jordan-tate-md-mph https://www.instagram.com/drjordantate/ Guest, Dr. Alexa Moreira MD: Dr. Moreira is PMR resident at University of Miami and part of the poster to podium program at ASPN. She will be a pain medicine fellow at Rush University this year. https://www.linkedin.com/in/alexandra-moreira/ https://www.linkedin.com/in/alexandra-moreira/ Guest member, Dr. Tolga Suvar MD: Dr. Suvar is an assistant professor of Anesthesia and Pain Medicine at Rush University. https://suvarmd.com/ About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Saluda Medical: Saluda is the first to directly measure the spinal cord's physiologic response to stimulation. A 10+ year journey since the first ECAP measurement to transform the science and practice of SCS using Evoked Compound Action Potentials (ECAPs) to pioneer smart neuromodulation therapy. The Evoke® System listens and responds to each patient's neural signature. https://www.saludamedical.com/ Nalu Medical: Nalu Offers a Long-Term Solution For Pain. More than just new technology; it's a whole new world of opportunities. https://nalumed.com/
In this episode we discussed Dr. Tim Deer's “The DO NOTHINGS” post. ASPN Vice President, Dr. Steven Falowsk, talked about his algorithm for low back pain, experience with the Reactiv8 therapy, and how he partners with industry. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Dr. Steven Falowski MD: Dr. Steven Falowski is currently Vice President of ASPN. He completed his neurosurgical residency training at Thomas Jefferson University in Philadelphia with a focus on spinal cord stimulation and pain management, complex spinal procedures, and treatment for movement disorders such as deep brain stimulation. https://asclancaster.com/physicians/steven-m-falowski-md/ About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Saluda Medical: Saluda is the first to directly measure the spinal cord's physiologic response to stimulation. A 10+ year journey since the first ECAP measurement to transform the science and practice of SCS using Evoked Compound Action Potentials (ECAPs) to pioneer smart neuromodulation therapy. The Evoke® System listens and responds to each patient's neural signature. https://www.saludamedical.com/
In this episode we take a deeper dive into the Boston Scientific acquisition of Relievent Medsytems. Dr. Ray Baker, CMO of Relievent Medsystems, discussed how he developed the Intracept procedure for commercialization. Jim Cassidy, President of Boston Scientific Neuromodulation talked about what he looks for when acquiring a therapy. Ray and Jim both gave great incites into the future of interventional pain and what needs to be done to ensure patient access. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Dr. Ray Baker, MD: Dr. Baker joined Relievant in July 2017 and serves as Chief Medical Officer. Prior to joining Relievant, Dr. Baker was VP and Executive Medical Director of EvergreenHealth Medical Group, EvergreenHealth, Kirkland, Washington. During his 15 years at EvergreenHealth, Dr. Baker held positions on the board of the Evergreen Surgical Center, Chaired the EvergreenHealth Medical Group Leadership Council and was Medical Director of their Spine and Musculoskeletal Programs. Guest, Jim Cassidy: Jim Cassidy is the president of the neuromodulation division at Boston Scientific. In this role, Jim leads the global neuromodulation business that helps people with chronic pain and neurological conditions through innovative therapies, including spinal cord stimulation, Vertiflex™ procedure, radiofrequency ablation systems, and deep brain stimulation. About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/
In this episode we talked with Dr. Anil Sharma about the Sharma foundation's partnership with ASPN. We then spoke with Dr. Krishnan Chakravarthy about his experience in turning an idea into a company. We discussed what VCs are looking for in a startup company and the key ingredients to launching a medical device company. We wrapped up the episode discussing the future of the interventional pain space. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Dr. Anil Sharma: Dr. Sharma is the founder and President of Spine & Pain Centers of New Jersey and New York. He received his fellowship training in Pain Management at the prestigious Cleveland Clinic Foundation. https://www.universityspinecenter.com/our-team/anil-k-sharma-md Guest, Dr. Krishnan Chakravarthy: Dr. Chakravarthy is an anesthesiologist who specializes in multi-modal pain management. He currently serves on the editorial board of several national and international peer-reviewed journals, and committees on organizations such as the International Neuromodulation Society, and American Society of Pain and Neuroscience. An entrepreneur, Dr. Chakravarthy is a founder of several biotechnology startup companies focusing on applications of nanotechnology in the pain space, and novel small molecule therapeutic development to advance pain care. https://nxtstim.com/ https://www.douleurtx.com/ https://stimfixanchors.com/ About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Vertos Medical: The company behind the mild Procedure. Move beyond palliative therapies and address a major root cause of LSS, without leaving any implants behind. https://www.vertosmed.com/ Spinal Simplicity: Minuteman is an outpatient, minimally invasive, spine fusion therapy that decreases recovery time, and can alleviate pain for patients with chronic back and leg pain. Minuteman stabilizes and fixates the spine, addressing the core etiology. Get back to life with Minuteman! https://spinalsimplicity.com/ APM Wealth: Justin Harvey is a financial advisor and founder of APM Wealth. He specializes in helping pain physicians make smart financial decisions. He also hosts a podcast called APMSucces. https://apm-wealth.com/ https://apmsuccess.com/ Moxy Company: Moxy is a marketing healthcare and communications firm with a strategic and deep understanding of the complex and ever-changing world of healthcare. https://www.moxycompany.com/
In this episode we discussed the current state of physicians adopting new therapies in the United States compared to internationally with Painteq CCO, Shanth Thiyagalingam. We also talked about the potential roadblocks and the regulation process in some of the global markets. We wrapped up the episode discussing the role of ISPN in expanding interventional pain therapies to the international market. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Dr. Shanth Thiyagalingam: Shanth is the chief commercial officer at Painteq. He has a vast amount of experience in the medical device field internationally working with St Jude Medical and Stryker in Australia and Southeast Asia. About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Vertos Medical: The company behind the mild Procedure. Move beyond palliative therapies and address a major root cause of LSS, without leaving any implants behind. https://www.vertosmed.com/ Spinal Simplicity: Minuteman is an outpatient, minimally invasive, spine fusion therapy that decreases recovery time, and can alleviate pain for patients with chronic back and leg pain. Minuteman stabilizes and fixates the spine, addressing the core etiology. Get back to life with Minuteman! https://spinalsimplicity.com/ APM Wealth: Justin Harvey is a financial advisor and founder of APM Wealth. He specializes in helping pain physicians make smart financial decisions. He also hosts a podcast called APMSucces. https://apm-wealth.com/ https://apmsuccess.com/ Moxy Company: Moxy is a marketing healthcare and communications firm with a strategic and deep understanding of the complex and ever-changing world of healthcare. https://www.moxycompany.com/
Join Peter Ravella and Tyler Buckingham in this rerun episode from November 15, 2020, as they host Peter Deneen, a former US Coast Guard officer, now turned environmental advocate. Dive into Peter's riveting journey from the disciplined life at the US Coast Guard Academy to his active service, and witness his transformative leap into environmental science. The conversation delves into how his experiences in the service shaped his perspective on environmental challenges and led to his current mission of fostering environmental optimism. Gain insights into his work with the Watershed Progressive and get introduced to his enlightening podcast, The Water Table. This episode promises to be a compelling blend of service stories, scientific discourse, and societal impact, exclusively on ASPN!
In this episode we discussed posterior interspinous fusion with Dr. Larry Khoo and Dr. Anuj Shah. We talked about patient selection, what to look for on imaging, and the safety profile of the Minuteman procedure. Dr. Khoo also discussed the biomechanics of interspinous fusion, including sagittal balance. We wrapped up the episode talking about how spine surgeons and pain physicians can work together to treat spinal stenosis. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Dr. Larry Khoo, MD: Dr. Khoo is a neurosurgeon who practices in Los Angeles, CA and Hawaii. Dr. Khoo is a resident member of the American Academy of Neurological Surgeons and the Congress of Neurological Surgeons, as well as a member of the AANS/CNS Joint Section on Spine & Peripheral Nerve Surgery and the North American Spine Society. Guest, Dr. Anuj Shah, DO: Dr. Shah is a PGY-4 PMR resident in Detroit, Michigan. He has matched in a pain fellowship at Cornell. About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Vertos Medical: The company behind the mild Procedure. Move beyond palliative therapies and address a major root cause of LSS, without leaving any implants behind. https://www.vertosmed.com/ Spinal Simplicity: Minuteman is an outpatient, minimally invasive, spine fusion therapy that decreases recovery time, and can alleviate pain for patients with chronic back and leg pain. Minuteman stabilizes and fixates the spine, addressing the core etiology. Get back to life with Minuteman! https://spinalsimplicity.com/ APM Wealth: Justin Harvey is a financial advisor and founder of APM Wealth. He specializes in helping pain physicians make smart financial decisions. He also hosts a podcast called APMSucces. https://apm-wealth.com/ https://apmsuccess.com/ Moxy Company: Moxy is a marketing healthcare and communications firm with a strategic and deep understanding of the complex and ever-changing world of healthcare. https://www.moxycompany.com/
In this rerun, join hosts Peter Ravella and Tyler Buckingham for a deep dive with Dr. Rodney Cluck, the Division Chief of Environmental Sciences at BOEM — the agency that shapes the energy landscape on the American Shoreline. With a shift in tides towards offshore wind energy, Dr. Cluck sheds light on BOEM's evolving mission, detailing the crucial role scientific research plays in guiding responsible offshore development. Discover the intersection of environmental stewardship and the burgeoning ocean economy as BOEM charts a course through the offshore wind surge. Tune in to uncover the scientific currents propelling the future of our nation's energy, right here on ASPN.
In this episode we discussed what it takes to get published with Dr. David Lee. He talked about the steps you need to take to get your name on a paper. We also discussed the pros and cons of industry funded studies. We wrapped up the episode talking about the importance of publishing. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Dr. David Lee, MD: Dr. Lee remains an active member in multiple medical organizations, holding leadership positions over the past few years. He continues to teach and present on a variety of pain-related topics on both regional and national levels. He reviews interventional spine and pain manuscripts for the journals of Regional Anesthesia & Pain Medicine, Pain Medicine and PM&R. https://www.davidwleemd.com/ About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Vertos Medical: The company behind the mild Procedure. Move beyond palliative therapies and address a major root cause of LSS, without leaving any implants behind. https://www.vertosmed.com/ Spinal Simplicity: Minuteman is an outpatient, minimally invasive, spine fusion therapy that decreases recovery time, and can alleviate pain for patients with chronic back and leg pain. Minuteman stabilizes and fixates the spine, addressing the core etiology. Get back to life with Minuteman! https://spinalsimplicity.com/ APM Wealth: Justin Harvey is a financial advisor and founder of APM Wealth. He specializes in helping pain physicians make smart financial decisions. He also hosts a podcast called APMSucces. https://apm-wealth.com/ https://apmsuccess.com/ Moxy Company: Moxy is a marketing healthcare and communications firm with a strategic and deep understanding of the complex and ever-changing world of healthcare. https://www.moxycompany.com/
In this episode, Peter Ravella and Tyler Buckingham welcome back Dr. Joseph Kunkel, Emeritus Professor at UMass Amherst and Research Professor at UNE Biddeford, to discuss the escalating concerns around lobster shell disease in the Gulf of Maine. Since his last appearance on the show in 2020—still one of our top 10 most-listened-to episodes—Joe has continued his groundbreaking research into this phenomenon. Tune in as he shares his latest findings, what this means for marine ecology, and how the lobster industry can navigate these turbulent waters. If you're interested in marine ecosystems or simply curious about the natural world, Joe's unique perspective, infectious curiosity, and excitement make this an episode that you won't want to miss. Listen now exclusively on ASPN!
In this episode we discussed the role of marketing in a medical practice with the CEO and founder of Moxy, Christy Owenby. She talked about how much physicians should spend on marketing and how they can track their return on investment. She also shares the DO's and DONT's on using social media for marketing. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Christy Owenby: Christy Owenby is the CEO and founder of Moxy. Moxy is a marketing healthcare and communications firm with a strategic and deep understanding of the complex and ever-changing world of healthcare. https://www.moxycompany.com About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Vertos Medical: The company behind the mild Procedure. Move beyond palliative therapies and address a major root cause of LSS, without leaving any implants behind. https://www.vertosmed.com/ Spinal Simplicity: Minuteman is an outpatient, minimally invasive, spine fusion therapy that decreases recovery time, and can alleviate pain for patients with chronic back and leg pain. Minuteman stabilizes and fixates the spine, addressing the core etiology. Get back to life with Minuteman! https://spinalsimplicity.com/ APM Wealth: Justin Harvey is a financial advisor and founder of APM Wealth. He specializes in helping pain physicians make smart financial decisions. He also hosts a podcast called APMSucces. https://apm-wealth.com/ https://apmsuccess.com/ Moxy Company: Moxy is a marketing healthcare and communications firm with a strategic and deep understanding of the complex and ever-changing world of healthcare. https://www.moxycompany.com/
Are you a physician looking to excel not just in clinical practice, but also in managing your career and building wealth? In this episode, we delve into the critical aspects of physician practice management and wealth-building with insights shared from a recent guest appearance on The Pain Unfiltered Podcast. Hosted by Dawood Sayed, MD, and Patrick Buchanan, MD, this conversation covers essential topics like choosing the right practice, deciphering employment contracts, and strategies for building wealth as a physician. Learn more: https://apmsuccess.com/217 Watch the video: https://apmsuccess.com/217v
In this episode we discussed how Dr. Ajay Antony and Dr. John Stevenson collaborated together and used the MILD procedure to treat their patients. They talked about the common challenges when introducing the MILD procedure or other minimally invasive surgical procedures to spine surgeons. They gave advice on how to establish a similar partnership between the pain physician and spine surgeon. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Dr. Ajay Antony, MD: Dr. Antony is a double board-certified anesthesiologist and interventional pain physician. He specializes in minimally invasive options to relieve pain and improve function. https://spinecarepartners.org/physician/ajay-antony-m-d/ Guest, Dr. John Stevenson, MD: Dr. Stevenson is a board-certified neurosurgeon who specializes in spine surgery. Dr. Stevenson became a neurosurgeon because of his love for neuroscience and the influence of his father. https://www.toi-health.com/physicians/john-c-stevenson-m-d/ About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Vertos Medical: The company behind the mild Procedure. Move beyond palliative therapies and address a major root cause of LSS, without leaving any implants behind. https://www.vertosmed.com/ Spinal Simplicity: Minuteman is an outpatient, minimally invasive, spine fusion therapy that decreases recovery time, and can alleviate pain for patients with chronic back and leg pain. Minuteman stabilizes and fixates the spine, addressing the core etiology. Get back to life with Minuteman! https://spinalsimplicity.com/ APM Wealth: Justin Harvey is a financial advisor and founder of APM Wealth. He specializes in helping pain physicians make smart financial decisions. He also hosts a podcast called APMSucces. https://apm-wealth.com/ https://apmsuccess.com/
The environmental and economic challenges of today require an interplay of sustainability, the rethinking of materials usage and the implementation of green technologies. The power, agriculture and industrial sectors are all part of this story. Here Oppenheimer's Sustainable Growth and Resource Optimization Team including Colin Rusch, Kristen Owen, and Noah Kaye, discuss the key elements and essential drivers in the Innovating Climate Solutions episode. Together, they discuss net zero emissions, resilient infrastructure, and who to watch. Podcast Disclosure: This podcast is the property of Oppenheimer & Co. Inc. and should not be copied, distributed, published or reproduced, in whole or in part. The information/commentary contained in this recording was obtained from market conditions and professional sources, and is educational in nature. The information presented has been derived from sources believed to be reliable but is not guaranteed as to accuracy and does not purport to be a complete analysis of any strategy, plan, security, company, or industry involved. Opinions expressed herein are subject to change without notice. Oppenheimer has no obligation to provide any updates or changes. Any examples used in this material are generic, hypothetical and for illustration purposes only. All price references and market forecasts are as of the date of recording. This podcast is not a product of Oppenheimer Research, nor does it provide any financial, economic, legal, accounting, or tax advice or recommendations. Any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. Securities and other financial instruments that may be discussed in this report or recommended or sold are not insured by the Federal Deposit Insurance Corporation and are not deposits or obligations of any insured depository institution. Investments involve numerous risks including market risk, counterparty default risk and liquidity risk. Securities and other financial investments at times maybe difficult to value or sell. The value of financial instruments may fluctuate, and investors may lose their entire principal investment. Prior to making any investment or financial decisions, an investor should seek advice from their personal financial, legal, tax and other professional advisors that take into account all of the particular facts and circumstances of an investor's own situation. The views and strategies described may not be suitable for all investors. This report does not take into account the investment objectives, financial situation or specific needs of any particular client of Oppenheimer or its affiliates. This presentation may contain forward looking statements or projections regarding future events. Forward-looking statements and projections are based on the opinions and estimates of Oppenheimer as of the date of this podcast, and are subject to a variety of risks and uncertainties as well as other factors, including economic, political, and public health factors, that could cause actual events or results to differ materially from those anticipated in the forward-looking statements and projections. Past performance does not guarantee future results. The performance of a benchmark index is not indicative of the performance of any particular investment; however, they are considered representative of their respective market segments. Please note that indexes are unmanaged and their returns do not take into account any of the costs associated with buying and selling individual securities. Individuals cannot invest directly in an index. In the past 12 months Oppenheimer & Co. Inc. has provided investment banking services for AEVA, ASPN, HASI, SHLS. In the past 12 months Oppenheimer & Co. Inc. has managed or co-managed a public offering of securities for ASPN, HASI, SHLS. In the past 12 months Oppenheimer & Co. Inc. has received compensation for investment banking services from ASPN, HASI, SHLS. Oppenheimer & Co. Inc. expects to receive or intends to seek compensation for investment banking services in the next 3 months from AEVA. Oppenheimer Transacts Business on all Principal Exchanges and Member SIPC 5962824.1
In this special episode, Peter Ravella and Tyler Buckingham are thrilled to announce a landmark collaboration with NOAA: the upcoming podcast "Planet NOAA: From Sun to Sea, and Everything in Between." Co-hosted by Peter and Aya Collins, Director of Communications and Education for the National Ocean Service, today's episode is more than just an announcement; it's an in-depth look at the journey that led to this partnership. Aya Collins and Lori Arguelles, NOAA's Director of Strategic Communications, join us to share personal insights and the story behind "Planet NOAA." Discover how this unique collaboration was conceived, get to know the personalities behind it, and learn what to expect from this riveting new show that will span topics from solar phenomena to ocean exploration.
In this episode we discussed how Justin Harvey came to specialize with pain physicians and why he partnered with ASPN. He talked about the different factors when choosing a practice and what to look for in an employment contract. Justin discussed several ways for physicians to build wealth and take advantage of taxes. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Special Guest Host, Dawood Sayed, MD: Dr. Dawood Sayed is a Professor in the Department of Anesthesiology, Pain and Perioperative Medicine at The University of Kansas Medical Center and a Board-certified Anesthesiologist at The University of Kansas Health System. https://www.kumc.edu/dsayed.html https://twitter.com/dsayed1 Guest, Justin Harvey, CFP: Justin Harvey is a financial advisor and founder of APM Wealth. He specializes in helping pain physicians make smart financial decisions. He also hosts a podcast called APMSucces. https://apm-wealth.com/ https://apmsuccess.com/ About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Vertos Medical: The company behind the mild Procedure. Move beyond palliative therapies and address a major root cause of LSS, without leaving any implants behind. https://www.vertosmed.com/ Spinal Simplicity: Minuteman is an outpatient, minimally invasive, spine fusion therapy that decreases recovery time, and can alleviate pain for patients with chronic back and leg pain. Minuteman stabilizes and fixates the spine, addressing the core etiology. Get back to life with Minuteman! https://spinalsimplicity.com/
In this special reairing for Labor Day, join Peter Ravella and Tyler Buckingham as they explore the extraordinary legacy of the USS New Jersey (BB-62), the most decorated battleship in U.S. Navy history. Guests Ryan Szimanski and Libby Jones provide an in-depth look at the ship's diverse service history, spanning World War II to the Cold War. Discover how the ship has been rejuvenated through digital media, allowing virtual access to this floating monument from the comfort of your home. Tune in for a deep dive into naval history and the innovative ways we can interact with it today—only on ASPN.
In this episode we discussed how to improve your brand as a physician and get involved with ASPN. Our guest, Dr. Melissa Murphy, shared her journey coming out of fellowship to now being one of the key opinion leaders in the pain medicine field. She shared her experience with the ASPN poster to podium program. Dr. Murphy, Dr. Deer, and Dr. Buchanan gave their advice on how to get involved with ASPN and enhance your brand. Takeaways from the episode: Dr. Murphy shared her experience with ASPN and the poster to podium program Dr. Murphy, Dr. Deer, and Dr. Buchanan shared their advice on professional development. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Host, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Dr. Melissa Murphy, MD: Dr. Murphy is a fellowship-trained, double-board-certified interventional spine and pain specialist. She is dedicated to working with each patient individually to develop a personalized treatment plan to improve function and quality of life. https://www.ntxortho.com/doctors/melissa-z-murphy-md-mph About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/ Vertos Medical: The company behind the mild Procedure. Move beyond palliative therapies and address a major root cause of LSS, without leaving any implants behind. https://www.vertosmed.com/
In this episode we discussed the various stimulation therapy options for low back pain. Our guest, Dr Rob Heros, shared his treatment algorithm for low back pain. He discussed the current data on different stimulation studies treating low back pain. He shared his experience with consulting for various medical device companies and the opportunities to be a research investigator in these studies. Dr. Heroes' patient shared his experience with low back pain and his treatment with Reactiv8. Takeaways from the episode: Dr. Heros shares his algorithm for low back pain and discusses the current data for stimulation to treat low back pain. Dr. Heros and Dr. Sayed discuss how they balance consulting and research with patient care Dr. Heros' patient shares his experience with Reactiv8 therapy. Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=en Special Guest Host, Dawood Sayed, MD: Dr. Dawood Sayed is a Professor in the Department of Anesthesiology, Pain and Perioperative Medicine at The University of Kansas Medical Center and a Board-certified Anesthesiologist at The University of Kansas Health System. https://www.kumc.edu/dsayed.html https://twitter.com/dsayed1 Guest, Dr. Rob Heros, MD: Dr. Heros is an interventional pain physician at Spinal Diagnostics in Oregon. He is board certified in Physical Medicine and Rehabilitation and has been practicing Pain Medicine for over 16 years. He has been involved in several landmark clinical research studies for stimulation to treat low back pain. https://spinaldx.com/ About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro Our sponsors: Mainstay Medical: The Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain caused by Multifidus Dysfunction. Restore Control, Restore Function, Restore Stability, ReActiv8 Life. https://mainstaymedical.com/
In this episode we announced our first sponsorship for Season 1, Mainstay Medical, and gave our thoughts on their therapy, Reactiv8. We discussed how Painteq president, Michael Enxing, got into the medical device industry and specifically the interventional pain space. He shared his advice to individuals that are just starting in the medical device industry. He discussed why he and his companies choose to partner with ASPN. He gave a few pearls of wisdom on how to partner with industry. He shared the key ingredients on how to commercialize a medical device company. Finally, he discussed where he thinks Painteq and the interventional pain space are headed. Takeaways from the episode: Mainstay Medical is the first sponsor for Season 1 Michael Enxing shares his advice for newcomers in the medical device industry and for physician looking to partner with industry We discuss where we think Painteq and the interventional pain space is headed Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=enHost, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Michael Enxing, President of Painteq Michael has been involved in the medical device industry for 3 decades. He has held several executive roles including the Global VP of Sales and Marketing for Nevro, CCO for Vertiflex, and CCO for Boston Scientific Neuromodulation Division. He has been a part of 4 acquisitions and mergers and 5 IPOs. He currently serves as the president of Painteq. About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro
Meet Aisha Marshall, a talented individual making waves as a Podcaster, Designer, Forbes 30 Under 30 honoree, Speaker, and Educator. With her diverse range of skills and experiences, she's leaving her mark in multiple fields. Aisha is the creative force behind Whxte Atelier, a fine jewelry brand that showcases her eye for design and craftsmanship. Her creations are elegant and captivating, reflecting her passion for unique pieces. Beyond her entrepreneurial ventures, Aisha hosts the Butterfly SZN podcast. Through thought-provoking conversations, she shares valuable insights on personal growth and empowerment, helping listeners navigate life's challenges. With a law school degree under her belt, Aisha brings a strong legal foundation and a nuanced perspective to her work. Her knowledge and expertise contribute to her success across various endeavors. Aisha is also a founding member of ASPN (Advancing Support for Parents Nationwide), a non-profit organization focused on resolving workplace-family conflicts. ASPN advocates for nationwide policy changes that prioritize family-centric benefits, fostering a supportive environment for working parents. Having a background in marketing and public relations, Aisha excels at effectively communicating ideas and connecting with diverse audiences. Her strategic approach and creativity have been instrumental in her achievements. Aisha Marshall is a dynamic force, using her talents and platforms to make a positive impact. Through innovative designs, thought-provoking conversations, and advocacy for family-centric workplace policies, she is dedicated to creating a better world and empowering others to reach their full potential. Follow Aisha on Instagram | @aisha Whxte - fine jewelry with feeling | memories made in gold https://whxte.com/ Follow Whxte Atelier on Instagram | @whxteatelier Text DEVO to 888-984-5013 to join my monthly devotional Watch the podcast on Youtube https://www.youtube.com/@itsbutterflyszn/podcasts Merch: https://6d5b1d.myshopify.com/ Podcast: https://podcasts.apple.com/us/podcast/butterfly-szn/id1458621216
In this landmark episode, hosts Peter Ravella and Tyler Buckingham take a pause from the usual guest interviews to reflect on an incredible milestone: The American Shoreline Podcast Network's 1,000th episode and the 5-year anniversary of Coastal News Today & ASPN. They take this time to discuss Peter's exciting move to Olympia, Washington and the thrill of exploring the new coastal landscape there. Then, Tyler offers listeners a sneak peek into the production of a humorous launch video he's working on for the Blue Robotics BlueBoat in British Columbia, a delightful spoof of the classic movie, JAWS. A heartfelt thanks to the invaluable contributors and collaborators who have helped shape their past 5 years and 1,000 episodes. As we look to the future, we are eager to see what new horizons await for CNT&ASPN, and coastal communities from around the American Shoreline.
Atlanta United beat Philadelphia 2-0 and looked good doing it. Joe (92.9 The Game, DirtySouthSoccer.com) and JSam (TheStriker.com, MLSSoccer.com) are back to go in-depth on the biggest win of the year. Special thanks to William Probus for the new ASPN logo! For more FSF and to join the discord, check out patreon.com/fivestripefinal
© 2020-2025 Ivy Podcast Discovery LLC
